IRIS

Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation.

BERNASCONI, PAOLO;LAZZARINO, MARIO
2005-01-01
2005
Medical Research, Diagnosis & Treatment contains studies of existing and developing diagnostic and therapeutic techniques, as well as specific classes of clinical intervention. Resources in this category emphasize the difference between normal and disease states, with the ultimate goal of more effective diagnosis and intervention. Specific areas of interest include pathology and histochemical analysis of tissue, clinical chemistry and biochemical analysis of medical samples, diagnostic imaging, radiology and radiation, surgical research, anesthesiology and anesthesia, transplantation, artificial tissues, and medical implants. Resources focused on the disease, diagnosis, and treatment of specific organs or physiological systems are excluded and are covered in the Medical Research: Organs & Systems category.
HAEMATOLOGICA
sì
WOS:000230633100015
s2.0-22544459376
Sì, ma tipo non specificato
Inglese, Medio (1100-1500)
Internazionale
STAMPA
90
979
981
LMC; Imatinib; molecular follow-up
6
info:eu-repo/semantics/article
262
Merante, S; Orlandi, E; Bernasconi, Paolo; Calatroni, S; Boni, M; Lazzarino, Mario
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/149045
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact